EPISODE · Jul 23, 2021 · 13 MIN
BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications
from Decera Clinical Education Oncology Podcast · host Decera Clinical Education
In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, provides a nursing-focused overview on available BTK inhibitors in the treatment of CLL and lymphomas. Topics in this podcast include:Rationale for inhibiting BTKMOA of BTK inhibitorsApproved BTK inhibitorsRecent clinical trial findingsLink to full program, including downloadable slidesets:https://bit.ly/3iwN9UbPresenter: Beth Faiman, PhD, MSN, APRN-BC, AOCNNurse PractitionerCleveland Clinic Taussig Cancer InstituteCleveland, Ohio Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Listen to Beth Faiman, PhD, MSN, APRN-BC, AOCN, provide a nursing-focused overview of BTK inhibitors in the treatment of CLL and other B-cell malignancies including the most recent evidence reported from major oncology conferences.
NOW PLAYING
BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m